We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Events

27 Jan 2025 - 30 Jan 2025
15 Feb 2025 - 17 Feb 2025

Nanotechnology Approach Locates and Removes Dangerous Endometriosis Lesions

By HospiMedica International staff writers
Posted on 27 Apr 2022
Print article
Image: Nanoparticles show promise for locating, removing endometriosis lesions (Photo courtesy of OSU)
Image: Nanoparticles show promise for locating, removing endometriosis lesions (Photo courtesy of OSU)

Endometriosis is a common gynecological condition in women of childbearing age. The endometrium is the innermost layer of the uterus, and endometriosis occurs when endometrium-like tissue forms lesions outside of the uterine cavity – usually involving the ovaries, the fallopian tubes and the tissue lining the pelvis. On rare occasions, endometrial tissue may spread beyond the pelvic region. There’s no cure for endometriosis, although surgical removal of the lesions can improve fertility. The downside, however, is that the lesions come back about half the time, and more than one-quarter of endometriosis surgery patients need three or more operations because it’s hard to find all of the diseased tissue that needs to be removed. Scientists have now developed a new nanotechnology approach for locating and removing the painful and dangerous lesions associated with endometriosis.

The research led by scientists at the Oregon State University (OSU, Corvallis, OR, USA) involves magnetic nanoparticles - tiny pieces of matter as small as one-billionth of a meter. An animal-model study showed that the iron oxide nanoparticles, injected intravenously, act as a contrast agent – they accumulate in the lesions, making them easier to see by advanced imaging such as MRI. And when exposed to an alternating magnetic field, a non-invasive procedure, the nanoparticles’ temperature soars to more than 120 degrees Fahrenheit, high enough for lesion removal via heat.

Magnetic hyperthermia had not previously been considered as a potential means of ablating endometriosis lesions because other magnetic nanoparticles have relatively low heating efficiency. The nanoparticles could only get hot enough after being directly injected into diseased tissue, which is not a realistic approach for endometriosis. The researchers overcame that problem by developing hexagonal-shaped nanoparticles that have more than six times the heating efficiency of conventional spherical nanoparticles when subjected to an alternating magnetic field.

Modifying the nanoparticles with a peptide - multiple amino acids linked in a chain – that targets a cellular receptor abundant in endometriosis cells enhanced their ability to accumulate in endometriosis lesions, the scientists said. Studies of mice with endometriotic tissue transplanted from macaques demonstrated the nanoparticles’ ability to eradicate the diseased cells following one session of magnetic hyperthermia.

“Endometriosis is a debilitating, systemic disease, and the need for an efficient, non-surgical method of removing the lesions is urgent,” said Oleh Taratula of the Oregon State University College of Pharmacy who led the research. “We invented targeted nanoparticles with extraordinary heating capabilities that enable the use of magnetic hyperthermia for the safe and efficient elimination of endometriosis lesions.”

Related Links:
Oregon State University 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Mattress Replacement System
Carilex DualPlus
New
Vertebral Body Replacement System
Hydrolift

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.